Relatório Final - Iniciação Científica em Imunogenética UFPR

in human natural killer cells. J exp med. V. 183, n. 3, p. 875-879, 1995.
MORRETA, L et al., “Human NK Cells: from surface receptors to the therapy of leukemias and solid tumors”. Frontiers in immunology. Vol 5, n. 87, 2014. doi:10.3389/fimmu.2014.00087
O’CONNOR GM, HART OM, GARDINER CM. Putting the natural killer cell in its place. Immunology V.117, n.1, p. 1–10, 2006.
OPAS/ OMS (DF). Folha informativa - HPV e câncer do colo do útero. [S. l.], Fevereiro 2019. Acesso em: 10 fev. 2020.
PARHAM, P. MHC class I molecules and kirs in human history, health and survival. Nature Reviews Immunology . V. 5, n.3, p. 201-214, 2005.
PARHAM, P. Taking license with natural killer cell maturation and repertoire development. Immunological Reviews, V. 214, n. 1, p. 155-160, 2006.
PRENDIVILLE, W.; DAVIES, P. HPV handbook – 1: Human papillomavirus and cervical cancer. Abingdon: Taylor & Francis, 2004.
RAJALINGMAN, R. The impact of HLA Class I-Specific Killer Cell Immunoglobulin-Like Receptors on Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity and Organ Allograft Rejection. Frontiers in Immunology. V. 27, n. 10, 2016.
RIZZO, R et al. Implication of HLA-C and KIR Alleles in Human Papillomavirus Infection and Associated Cervical Lesions. Viral immunology, V. 27, n. 9, p. 468-470, Novembro de 2014.
SANTOS, C et al. HPV-transgenic mouse models: Tools for studying the cancer-associated imune response. Virus Research. V. 235, p.49-57, 2017.
SCHIFFMAN et al. Human Papillomavirus Testing in the Prevention of Cervical Cancer. Jornal of the National Center Institute. V. 103, n. 5, p. 368-383, 2011
SONG, M.J et al. Association of KIR genes and HLA‐C alleles with HPV‐related uterine cervical disease in Korean women. Tissue Antigens, [s. l.], v. 81, p. 134-170, Março de 2013.
TORRES, M.A; MORAES, M.E. Nomenclatura dos fatores do sistema HLA. Einstein. São Paulo. V 9, n. 2, p. 249-251, Junho de 2011.
UGLOTTI, E. et al, Human leukocyte antigen-B (-Bw6/ -Bw4 I80, T80) and human leukocyte antingen-C (-C1/ -C2) subgrouping using pyrosequence analysis. Human Immunology, [s. l.], V. 72 n. 10 p. 859-868, 2011
VILLIERS , E.M et al. Classification of papillomaviruses. Virology, [s. l.], v. 324, ed. 1, p. 17-27, 2004.
XAVIER, M.B.S. Análise epidemiológica e de gene relacionado ao sistema imune (HLA-C – Classe I) e neoplasias intraepitelial cervical II e III. Tese de mestrado em genética, Universidade Federal do Paraná, Curitiba, 2012.
	
WALBOOMERS, J. M. et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. [s. l.], V. 189, n. 1, p. 12-19, 1999.
ZUR HALSEN, H. Papilomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. [s. l.]. V. 2, n. 5, p. 342-350. 2002